Valor20212022202320242025Total de pasivos28.15 M27 M27.51 M30.19 M23.88 MCapital total252.56 M243.2 M187 M130.13 M74.29 MTotal de pasivos y patrimonio neto280.71 M270.2 M214.51 M160.33 M98.17 MDeuda total—————Deuda neta—————
Barinthus Biotherapeutics plc - American Depositary Shares
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.